2. Stryker Corporation (NYSE:SYK)
Current Stock Price as of Writing: $269.75
Mako combines an established robotic platform with a substantial orthopedic business.
Stryker Corporation (NYSE: SYK) has spent years building its Mako robotic-assisted surgery franchise. Its fourth-generation Mako system is designed to support applications across hip, knee, spine and shoulder procedures. The appeal is the connection between surgical technology and the company’s wider presence in orthopedics.
That connection gives Stryker Corporation (NYSE: SYK) an advantage over a company whose robot has yet to reach routine hospital use. Surgeons need systems that fit their procedures, while hospitals need equipment they can use regularly. A wider set of applications could strengthen the case for a system, although investors should still look for evidence of adoption and economic returns.
Stryker Corporation (NYSE: SYK) ranks second because it offers a strong combination of operating scale and direct exposure to robotic surgery. At its September 24 quote, buyers must still decide whether the share price adequately reflects the company’s prospects. A good robotics franchise is not a reason to ignore valuation.
